Autolus Therapeutics (AUTL) Misses Q3 EPS by 1c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c